Want to join the trial?
Choose a location to contact our Clinical Trial Coordinator and to discuss potential opportunities.
Contact to discuss potential opportunities.
Email CoordinatorOverview
SPHERES NMOSD Registry: CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
Description
This is a Prospective, observational research study for patients with NMOSD under the care of a licensed neurologist. Approximately 800 patients and 35 clinical sites in North America will be recruited to participate with no defined upper limit for either target.
Learn more at clinicaltrials.gov
Eligibility Criteria
Inclusion
- Has a diagnosis of NMOSD at the time of enrollment according to the 2015 IPND consensus diagnostic criteria for NMOSD†.
- Age 18 years or older at the time of enrollment.
- Willing to provide Personal Information.
Exclusion
- Has had a clinically confirmed NMOSD neuro-episode within the 12 weeks prior to enrollment.
- Is participating or planning to participate in a double-blind randomized trial for an NMOSD drug. Note: Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.
- All serology types (APQ4 +/- and MOG +/-) are eligible to enroll in the registry given they meet the 2015 IPND diagnostic criteria.